HAPPENING NOW: The Global Forum for Vaccine Sovereignty and Innovation is taking place in Paris, France, hosted by Gavi, the Vaccine Alliance . Follow it live here: bit.ly/45zg0iJ #RwandaFDA #VaccineSovereignty #Innovation #forourfuture

“In the urgency of the moment, Africa and its partners vowed to work together to build vaccine research and manufacturing capabilities for the long term. Once the pandemic passed, it would have been easy to forget this commitment and go back to business as usual.”- President

“As a continent, recent global shocks have taught us many lessons. Perhaps, the most important is to take ownership of our future and our health.”- President #Kagame #RBANews

“The more ambitious objective we should aim for is to create new vaccines and therapies that target Africa’s disease burden, using the latest technology platforms. Almost all new vaccine and drug discovery is taking place using these platforms, increasingly with artificial

On the sidelines of today's #AVMA launch with Gavi in France, Rwanda FDA and ANSM signed an MoU to facilitate bilateral cooperation on medicines & vaccines. The signing was witnessed by Minister Yvan Butera of Ministry of Health | Rwanda, and Minister Chrysoula Zacharopoulou 🇪🇺🇫🇷 of France Diplomatie🇫🇷🇪🇺

Today, the Director General of Rwanda Food and Drugs Authority, Prof. Dr. Emile Bienvenu received a U.S. FDA delegation, led by FDA Global ’s Mark Abdoo, Associate Commissioner for Global Policy and Strategy. Their discussion centered on future collaboration. #FDA #Collaboration

🚨🚨🔊Rwanda FDA iramenyesha Abaturarwanda bose ko ihagaritse ikwirakwizwa, n’ikoreshwa rya nimero A4042 y'umuti witwa EFFERALGAN VITAMINE C 500mg/200mg ("comprimé effervescent"), ukorwa n'uruganda rwitwa UPSA SAS rwo mu Bufaransa. #Recall #HealthAlert

🚨🚨🔊Rwanda FDA informs the general public about the recall of Batch No. A4042 of EFFERALGAN VITAMINE C 500mg/200mg ("comprimé effervescent") manufactured by UPSA SAS, France. #Recall #HealthAlert

🚨🚨🔊Gukura ku isoko nimero 23038 y’umuti witwa TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1% W/W STERILE, wakorewe mu Buhinde. — 🚨🚨🔊 Rwanda FDA recalls Batch No. 23038 of TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1% W/W STERILE. #Recall #HealthAlert

“I am addressing this message in particular to Rwanda’s young people, especially those born over the last thirty years. This country is yours to protect, defend, and make prosperous. It is worth repeating that real liberation only begins when the guns fall silent.” President

World Health Organization (WHO)🇷🇼 World Health Organization (WHO) HQ WHO African Region Rwanda Food and Drugs Authority with #SADC & #EAC are training 11🌍 Regulators (NRAs) on World Health Organization (WHO) Collaborative Registration Procedure #CRP for medical products. With +65 countries, #CRP facilitates rapid approval of access to quality-assured medicines through reliance among #NRA

Following Rwanda FDA’s recent recall of Efferalgan Vitamin C 500mg/200mg (Batch No. A4042), the COMESA Competition Commission has issued a similar notice. #HeathAlert #ProductRecall

Thanks to Members of the SC for the WHO Member State Mechanisms on Substandard and Falsified Medical Products for a productive SC meeting in Geneva (9 – 10 July 2024) World Health Organization (WHO). #RwandaFDA

🔔 TWIBUKIRANYE! Zirikana ko gupfunyika ibinyobwa bisembuye muri palasitiki bitemewe. —————————— 🔔 A reminder to alcoholic beverage manufacturers and retailers! ➡️ Read the circular here: bit.ly/3Sli1Km #AlcoholicBeverages #Packaging #Regulations #RwandaFDA

Rwanda FDA, University of Rwanda, Rwanda Forensic Institute (RFI), Rwanda Biomedical Centre, and ABI, signed an MoU with ICGEB Official . Rwanda Food and Drugs Authority will benefit from exposure to ICGEB state-of-the-art lab facilities and GMP training for new technologies relating to biological manufacturing. The signing was witnessed by the

🚨🚨🔊Rwanda FDA iramenyesha Abaturarwanda bose ko ihagaritse ikwirakwizwa, n’ikoreshwa rya Discovery White Vinegar yakozwe na TAMU TAMU HEAT SPICES LTD ndetse na HLAAL White Vinegar yakozwe na CHEETER GROUP LTD, nyuma yo gufunga ibi bigo byakoraga nk’inganda mu buryo butemewe.

DG Prof. Dr. Emile Bienvenu received Dr. Douglas N. Shaffer, the Deputy Director General of Global Affairs & Communications, and Dr. Anh Wartel, the Deputy Director General of Clinical, Assessment, Regulatory, and Evaluation, from International Vaccine Institute (IVI). Their discussion centered on

The International Vaccine Institute (IVI) has organised in Kigali the International Vaccinology Course (IVC) from 2nd to 6th September 2024. Rwanda FDA received IVC participants from various countries. They toured Rwanda Food and Drugs Authority's headquarters and explored its functions, including